Methylnaltrexone and rifaximin treatments significantly improve chronic "leaky gut" in a diet-induced mouse model of non-alcoholic fatty liver disease

GASTROENTEROLOGY(2020)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要